Hysingla ER is an extended-release medication that provides around-the-clock relief from severe pain. Consequently, doctors prescribe this drug, to treat ongoing pain rather than as an as-needed basis for pain. Hysingla ER contains hydrocodone, which is an opioid pain reliever. This medication is available in 20 mg, 30 mg, 40 mg, 60 mg, 80 mg, 100 mg and 120 mg film-coated tablets. The tablet strength indicates the amount of hydrocodone in each tablet.
Hysingla ER tablets are for oral use only. Also, crushing, chewing, or dissolving this medication can case rapid release and absorption of hydrocodone, which can be fatal. Therefore, this medication also contains ingredients that make it more difficult to abuse intravenously. Hydrocodone is an opioid, sometimes called a narcotic. In fact, all opioids, including the hydrocodone in Hysingla ER, present the risk for addiction, abuse, and misuse – even at recommended doses. Extended release opioid formulations, like this one, poses greater risks of overdose and death. Additionally, due to these risks, clinicians should reserve it use for only those patients for whom non-opioid analgesics, immediate-release opioids, and other alternative treatment options are ineffective, not tolerated, or otherwise inadequate for the management of pain.
All medications can produce side effects, including allergic reaction. However, some side effects are not serious and disappear with continued use at recommended doses. Other side effects, especially allergic reactions, require immediate medical attention. Signs of an allergic reaction can include hives, difficulty breathing, and swelling of the face, lips, tongue, or throat.
Consumers should stop using Hysingla ER and contact the prescribing clinician if they have weak or shallow breathing, pain or burning upon urination, confusion, tremors, severe drowsiness, or dizziness. Breathing problems are more likely in older adults and in severely ill, malnourished, or otherwise debilitated patients.
Common side effects can include:
Hysingla ER can cause a serious, life-threatening, or fatal breathing problem known as respiratory depression. The risk for respiratory depression is greatest during initiation or following a dose increase. Certainly Individuals with breathing problems, severe asthma, or blockage of the stomach or intestines should not use this drug without a careful discussion with the prescribing physician. In addition to breathing problems, it can also cause behavior changes, addiction and withdrawal symptoms.
If some of the below severe side effects occur, you should seek emergency help:
*These are not all the possible side effects of Hysingla ER and it should not be used as medical advice. Therefore, call your doctor for medical advice about side effects.
Tolerance, physical dependence and addiction can develop during daily intake while following a opioid therapy. The development of tolerance will cause a need for increasing doses of in order to maintain a expected effect and result. Tolerance may develop at different rates for different effects and it can be affected by a variety of factors. Misuse of this drug or other opiate narcotic medication can result in addiction, overdose or death, especially when the proper medical supervision is not followed, or patients are using it without a prescription. Patients that are prescribed this medication for personal use, should never share this medication with another person, especially with a person with a history of drug abuse or addiction.
Prolonged use during pregnancy can result in neonatal withdrawal syndrome, which could be life threatening if not properly assessed and immediately treated; Treatmnet might require specialized protocols developed by neonatology experts.
Because of the high risks of the high potential of abuse, dependence and addiction, even at recommended doses and because of the greater risks of overdose and death with extended-release formulations; Purdue states that this drug should only be use in patients for whom alternative treatment options has shown to be ineffective, not tolerated, or has not provided the sufficient management of pain.
It is crucial to assess each patient’s risk prior to prescribing such drug, and the prescribing doctor should monitor all patients regularly for the development of the above behaviors or conditions.
If the use is abruptly discontinued or sharply decreased, abstinence syndrome ( withdrawal ) may occur.
Some of the following can characterize this syndrome:
Withdrawal symptoms can be very uncomfortable and persistent, lasting for days or even weeks. Consequently stubborn and overwhelming withdrawal symptoms can make it very difficult to stop using Hysingla ER.
Speak With an Addiction Specialist
Exceptional Care & Better Outcome. Get In Touch With Us Today!
Hysingla ER detoxification is a medical procedure that helps consumers stop using this opioid pain medication. Above all, medical opiate detoxification is a safe and effective procedure that includes medications that reduce the symptoms of withdrawal and close monitoring by highly trained medical personnel.
Waismann Method® of medical detoxification helps patients through the Hysingla ER withdrawal process in a private full service accredit hospital; while under supervision of medical experts. In essence our mission is to detox patients in the most compassionate, private and effective manner possible. In order to achieve this goal, we utilize the most advanced medical resources and facilities. For example our facilities are staffed by some of the country’s top opioid detoxification experts and physicians. In fact we create individualized programs that serve a each patient specific medical and personal needs.
What's New at Waismann Method®
The effects of opiate addiction reach far beyond the individual suffering from this powerful disorder; it profoundly impacts an entire family system. Families struggling alongside